Up-regulation of tension-related proteins in keloids: Knockdown of hsp27, α2β1-integrin, and pai-2 shows convincing reduction of extracellular matrix production

Plastic and Reconstructive Surgery

Volumn 131, Issue 2, 2013, Pages

  Suarez, Edna ^a   Syed, Farhatullah ^a   Alonso Rasgado, Teresa ^a   Mandal, Parthasarathi ^a   Bayat, Ardeshir ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; PLASMINOGEN ACTIVATOR INHIBITOR 2; VERY LATE ACTIVATION ANTIGEN 2;

ADOLESCENT; ADULT; AGED; ARTICLE; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; KELOID; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; UPREGULATION;

ADOLESCENT; ADULT; AGED; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INTEGRIN ALPHA2BETA1; KELOID; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 2; UP-REGULATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84873304818     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182789b2b     Document Type: Article

References (50)

1. Eckes B, Zweers MC, Zhang ZG, et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc. 2006;11:66-72. (Pubitemid 44413146)
2. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: Clinical implications for lesional site-directed therapy. Br J Dermatol. 2011;164:83-96.
3. Seifert O, Mrowietz U. Keloid scarring: Bench and bedside. Arch Dermatol Res. 2009;301:259-272.
4. Shih B, Brown J, Armstrong D, Lindau T, Bayat A. Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue. Hand (N Y.) 2009;4:294-301.
5. Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2009;18:139-153.
6. Tomasek JJ, Gabbiani G, Hinz B, Chapponier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349-363. (Pubitemid 34619269)
7. Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: Neurogenic inflammation hypotheses. Med Hypotheses 2008;71:32-38.
8. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease: Transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol. 2004;13:120-124. (Pubitemid 38247871)
9. Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302:319-339.
10. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol. 2009;161:8-18.
11. Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ. 2003;326:88-92. (Pubitemid 36092292)
12. Ogawa R, Akaishi S, Huang C, et al. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: The importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch. 2011;78:68-76.
13. Altun V, Hakvoort TE, van Zuijlen PP, van der Kwast TH, Prens EP. Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars: A 7-month follow-up study of 22 patients. Burns 2001;27:717-722. (Pubitemid 32910616)
14. Bayat A, Arscott G, Ollier WE, Ferguson MW, McGrouther DA. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg. 2004; 57:122-133. (Pubitemid 38239884)
15. Margadant C, Sonnenberg A. Integrin-TGF-crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010;11:97-105.
16. Wang Z, Fong KD, Phan TT, Lim IJ, Longaker MT, Yang GP. Increased transcriptional response to mechanical strain in keloid fibroblasts due to increased focal adhesion complex formation. J Cell Physiol. 2006;206:510-517. (Pubitemid 43062822)
17. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg. 2008;206:731-741.
18. Chiquet M. Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol. 1999;18:417-426.
19. Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun. 2003;304:505-512. (Pubitemid 36506523)
20. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol. 2007;213:565-573. (Pubitemid 350058247)
21. Garrido C, Fromentin A, Bonnotte B, et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 1998;58:5495-5499. (Pubitemid 28551136)
22. Kuwano K, Araya J, Hara H. Molecular targets in idiopathic pulmonary fibrosis. Respir Circ. 2007;58:979-985.
23. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: The myofibroblast in focus. Chest 2007;132:1311-1321. (Pubitemid 47621009)
24. Yoshida T, Ohnuma A, Horiuchi H, Harada T. Pulmonary fibrosis in response to environmental cues and molecular targets involved in its pathogenesis. J Toxicol Pathol. 2011;24: 9-24.
25. Shih B, McGrouther DA, Bayat A. Identification of novel keloid biomarkers through profiling of tissue biopsies versus cell cultures in keloid margin specimens compared to adjacent normal skin. Eplasty 2010;10:e24.
26. Russell SB, Russell JD, Trupin KM, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol. 2010;130:2489-2496.
27. Syed F, Thomas AN, Singh S, Kolluru V, Emeigh Hart SG, Bayat A. In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties. PLoS One 2012;7:e31430.
28. Bagabir R, Syed F, Paus R, Bayat A. Long-term organ culture of keloid disease tissue. Exp Dermatol. 2012;21:376-381.
29. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg. 2001;107:87-96. (Pubitemid 32039240)
30. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease and hypertrophic scarring: Transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg. 2003;111: 535-543; discussion 544-546. (Pubitemid 36182284)
31. Bayat A, Arscott G, Ollier WE, McGrouther DA, Ferguson MW. Keloid disease: Clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58:28-37. (Pubitemid 40089678)
32. Wong VW, Akaishi S, Longaker MT, Gurtner GC. Pushing back: Wound mechanotransduction in repair and regeneration. J Invest Dermatol. 2011;131:2186-2196.
33. Wong VW, Rustad KC, Akaishi S, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med. 2011;18:148-152.
34. Kessler D, Dethlefsen S, Haase I, et al. Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem. 2001;276:36575-36585.
35. Langholz O, Röckel D, Mauch C, et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol. 1995;131:1903-1915. (Pubitemid 26007985)
36. Strehlow D, Jelaska A, Strehlow K, Korn JH. A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. J Clin Invest. 1999;103:1179-1190. (Pubitemid 29207252)
37. Lavker RM, Risse B, Brown H, et al. Localization of plasminogen activator inhibitor type 2 (PAI-2) in hair and nail: Implications for terminal differentiation. J Invest Dermatol. 1998;110:917-922. (Pubitemid 28237698)
38. Hirano S, Rees RS, Gilmont RR. MAP kinase pathways involving hsp27 regulate fibroblast-mediated wound contraction. J Surg Res. 2002;102:77-84. (Pubitemid 34969452)
39. Lavoie JN, Hickey E, Weber LA, Landry J. Modulation of actin-microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem. 1993; 268:24210-24214. (Pubitemid 23335406)
40. Salinthone S, Tyagi M, Gerthoffer WT. Small heat shock proteins in smooth muscle. Pharmacol Ther. 2008;119: 44-54.
41. Charette SJ, Lavoie JN, Lambert H, Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol. 2000;20:7602-7612.
42. Lian X, Yang T. Plasminogen activator inhibitor 2: Expression and role in differentiation of epidermal keratinocyte. Biol Cell 2004;96:109-116. (Pubitemid 38391193)
43. Croucher DR, Saunders DN, Lobov S, Ranson M. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 2008;8:535-545. (Pubitemid 351881848)
44. Kessler-Becker D, Smola S, Krieg T, Eckes B. High plasminogen activator inhibitor type 2 expression is a hallmark of scleroderma fibroblasts in vitro. Exp Dermatol. 2004;13:708-714. (Pubitemid 39481024)
45. Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG. Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg. 2001;54:511-516.
46. Totan S, Echo A, Yuksel E. Heat shock proteins modulate keloid formation. Eplasty 2011;11:e21.
47. Xiao Y, Li H, Bunn C, Bartold PM. The expression of plasminogen activator system in a rat model of periodontal wound healing. J Periodontol. 2001;72:849-857. (Pubitemid 33665212)
48. Wang Z, Leisner TM, Parise LV. Platelet alpha2beta1 integrin activation: Contribution of ligand internalization and the alpha2-cytoplasmic domain. Blood 2003;102:1307-1315. (Pubitemid 36988037)
49. Mildner M, Ballaun C, Stichenwirth M, et al. Gene silencing in a human organotypic skin model. Biochem Biophys Res Commun. 2006;348:76-82. (Pubitemid 44163484)
50. Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 2006;13: 541-552.